February 9th News On February 7th, the equipment installation for the 6,000-ton high-purity crystalline lithium hexafluorophosphate (LiPF6) expansion and renovation project of Hubei Hongyuan Pharmaceutical Co., Ltd. was completed. Chempricehub Analysis on Lithium Hexafluorophosphate (LiPF6) Bull-Bear Score: -1 The completion of equipment installation for Hubei Hongyuan Pharmaceutical’s 6,000-ton high-purity crystalline LiPF6 expansion and renovation project indicates a significant upcoming increase in production capacity. The expectation of increased supply is likely to exert downward pressure on spot prices, particularly against the backdrop of currently weak demand growth, which may lead to an imbalance between market supply and demand. Therefore, a generally bearish score is assigned, and it is recommended to monitor the actual impact of subsequent production progress on prices.